Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 12, 2026, to request to lead the case, which is pending in the U.S. District Court for the Eastern District of Virginia [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Stride securities [2]. Group 2: Allegations Against Stride - Stride, an education technology company, allegedly inflated enrollment numbers by retaining "ghost students" and ignored compliance requirements, leading to poor customer experiences and higher withdrawal rates [3]. - The company claimed to be experiencing growth and strong demand, which is contradicted by the allegations of inflated enrollment figures and compliance failures [3]. Group 3: Stock Price Impact - On September 14, 2025, a report of the fraud allegations caused Stride's stock to drop by $18.60, or over 11%, from $158.36 to $139.76 per share [4]. - Following Stride's admission of poor customer experience on October 28, 2025, the stock plummeted by $83.48, or more than 54%, from $153.53 to $70.05 per share, with an estimated impact of 10,000-15,000 fewer enrollments [5].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Inspire Medical Systems develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Lawsuit Details - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Inspire stock, with the case pending in the U.S. District Court for the District of Minnesota [3]. - Investors have until January 5, 2026, to request to be appointed to lead the case [3]. Stock Performance and Issues - Inspire assured investors that it had taken necessary steps for the launch of Inspire V, but failed to prepare clinicians and payors, leading to significant delays and weak demand [5][6]. - On August 4, 2025, Inspire disclosed an "elongated timeframe" for the Inspire V launch and reduced its 2025 earnings per share guidance by over 80%, attributing this to undisclosed factors including incomplete training at implanting centers and poor demand due to excess inventory of older devices [7]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [5]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [5]. - Following the financial report, CarMax's stock dropped $11.45 per share, or roughly 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [6]. - An unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock drop of over 24% [6]. Group 3: Company Background - CarMax is a leading retailer of used cars, emphasizing a seamless customer experience and strong demand for its vehicles [3]. - The law firm Bleichmar Fonti & Auld LLP, which is representing the plaintiffs, has a notable track record in securities class actions and has recovered significant amounts for investors in previous cases [10].

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Cogent Communications Holdings, Inc., focusing on possible false or misleading statements made by the company and its executives [1]. Company Overview - Cogent Communications provides high-speed internet access, private network, and data center colocation space services [3]. Financial Performance - On November 6, 2025, Cogent Communications reported a nearly 6% year-over-year decrease in service revenue for the third quarter of 2025 [3]. - The company announced a significant dividend cut of 98%, reducing it from $1.015 per share in the previous quarter to $0.02 per share [3]. - Following the financial disclosures, Cogent Communications' share price fell nearly 35% [3].

Core Viewpoint - Kaskela Law LLC has initiated an investigation into Atkore Inc. to assess potential violations of securities laws or breaches of fiduciary duties by the company and its executives in relation to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of Atkore's shareholders [1]. - Shareholders are encouraged to reach out to Kaskela Law LLC for more information regarding their legal rights and options [2]. - Kaskela Law LLC specializes in representing investors in cases of securities fraud, corporate governance, and merger & acquisition litigation [2].

Core Viewpoint - Kaskela Law LLC has initiated an investigation into Select Medical Holdings Corporation to assess potential violations of securities laws or breaches of fiduciary duties by the company and its executives in relation to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of Select Medical's shareholders [1]. - Shareholders are encouraged to reach out to Kaskela Law LLC for more information regarding their legal rights and options [2]. - Kaskela Law LLC specializes in representing investors in cases related to securities fraud, corporate governance, and merger & acquisition litigation [2].

Group 1 - Halper Sadeh LLC is investigating Clearwater Analytics Holdings, Inc. and Janus Henderson Group plc for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their respective sales [1][2] - Clearwater Analytics is being sold to Permira and Warburg Pincus for $24.55 per share in cash, while Janus Henderson is being sold to Trian Fund Management and General Catalyst for $49.00 per share in cash [1][2] - The firm may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders, operating on a contingent fee basis [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC free of charge to discuss their legal rights and options [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Charming Medical Limited ("Charming†or the "Company†) (NASDAQ: MCTA) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHARMING MEDICAL LIMITED (MCTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 11, 2025, after market hours, the SEC issu. ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of SLM Corporation a/k/a Sallie Mae ("SLM†or the "Company†) (NASDAQ: SLM) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SLM CORPORATION (SLM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On August 14, 2025, investment bank TD Cowen issued a report s. ...

Core Viewpoint - Investors in Sprouts Farmers Market, Inc. have the opportunity to lead a securities fraud class action lawsuit due to substantial losses incurred as a result of misleading statements made by the company regarding its financial health and market position [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that from June 4, 2025, to October 29, 2025, Sprouts failed to disclose critical information about its customer base's resilience to macroeconomic conditions [3]. - It is claimed that the company misrepresented its ability to cope with economic changes and that the anticipated "trade-down" dynamics would not provide the expected sales boost [3]. - The lawsuit also contends that Sprouts' guidance on comparable sales and reported figures did not accurately reflect its growth trajectory, indicating a significant slowdown in sales growth due to cautious consumer behavior [3]. Group 2: Participation Information - Investors who suffered losses in Sprouts Farmers Market, Inc. are encouraged to contact the Law Offices of Howard G. Smith before January 26, 2026, to participate in the ongoing lawsuit [2][4]. - The law firm provides various contact methods for investors to discuss their legal rights and options regarding the class action [4][5].